High-density multiplexed antibody arrays can now contain 2,000 antibodies or more in a single panel. An ever-increasing pool of validated antibodies puts arrays at the forefront of biomarker discovery and development, and makes finding multiple biomarkers in a single screen more accessible than ever before.
Antibody arrays, with their high-throughput multiplexed design, not only offer insight into disease, but also help mine potential new drug targets. From asthma to cancer, neurological disease to heart failure, antibody arrays have been successful in discovering biomarkers in many disease areas. Arrays are used to identify protein panels, which can be used as biosignatures for clinical diagnosis, disease classification, disease prediction, drug development, and for optimizing patient care.
Antibody arrays, with their high-throughput multiplexed design, not only offer insight into disease, but also help mine potential new drug targets. From asthma to cancer, neurological disease to heart failure, antibody arrays have been successful in discovering biomarkers in many disease areas. Arrays are used to identify protein panels, which can be used as biosignatures for clinical diagnosis, disease classification, disease prediction, drug development, and for optimizing patient care.
Download this original eBook from The Scientist's Creative Services Division and RayBiotech to learn more about:
- Why we need to screen for candidate biomarkers
- The journey of a biomarker candidate through to the clinic
- Using arrays for biomarker discovery
- How arrays have been pivotal in cancer research
